Bank of New York Mellon Corp - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 94 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$876,000
-60.9%
706,497
-3.0%
0.00%
-100.0%
Q1 2017$2,243,000
-23.1%
728,210
+1.9%
0.00%0.0%
Q4 2016$2,915,000
-30.3%
714,546
+8.6%
0.00%0.0%
Q3 2016$4,180,000
+14.4%
658,214
-2.9%
0.00%0.0%
Q2 2016$3,654,000
-33.9%
678,029
+2.7%
0.00%
-50.0%
Q1 2016$5,525,000
+7.3%
660,162
+1.3%
0.00%0.0%
Q4 2015$5,147,000
-5.8%
651,489
+1.5%
0.00%0.0%
Q3 2015$5,464,000
-45.4%
642,019
-20.7%
0.00%
-33.3%
Q2 2015$10,011,000
+10.5%
809,596
+6.2%
0.00%
+50.0%
Q1 2015$9,056,000
+4.9%
762,206
-0.3%
0.00%0.0%
Q4 2014$8,637,000
+27.1%
764,249
-1.2%
0.00%0.0%
Q3 2014$6,794,000
-41.6%
773,743
-51.5%
0.00%0.0%
Q2 2014$11,636,000
+119.5%
1,596,168
+51.8%
0.00%
+100.0%
Q1 2014$5,300,000
-3.9%
1,051,642
+1.7%
0.00%
-50.0%
Q4 2013$5,514,000
-28.3%
1,034,387
-49.0%
0.00%
+100.0%
Q3 2013$7,694,000
+9.7%
2,029,778
+95.0%
0.00%
-50.0%
Q2 2013$7,016,0001,041,0200.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2013
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 1,560,530$17,634,0004.71%
B & T Capital Management DBA Alpha Capital Management 280,113$3,165,0002.22%
Schonfeld Group Holdings LLC 10,000$113,0001.51%
COLUMBIA CAPITAL LLC 117,702$1,331,0001.45%
Portolan Capital Management 607,288$6,862,0001.38%
Price Capital Management, Inc. 118,047$1,334,0001.18%
GARRISON BRADFORD & ASSOCIATES INC 90,700$1,025,0000.93%
Opus Point Partners Management, LLC 72,009$814,0000.80%
EAM Investors, LLC 412,233$4,658,0000.65%
TFS CAPITAL LLC 476,105$5,380,0000.51%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders